Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1890 1
1907 1
1908 1
1909 1
1910 4
1911 1
1912 1
1913 1
1914 2
1915 1
1916 1
1921 1
1923 1
1925 2
1926 1
1927 1
1933 2
1934 1
1935 1
1937 1
1944 2
1945 17
1946 31
1947 61
1948 145
1949 91
1950 133
1951 254
1952 296
1953 259
1954 287
1955 255
1956 239
1957 229
1958 143
1959 97
1960 78
1961 105
1962 128
1963 211
1964 304
1965 199
1966 192
1967 245
1968 282
1969 224
1970 264
1971 312
1972 250
1973 369
1974 400
1975 469
1976 549
1977 507
1978 501
1979 421
1980 281
1981 277
1982 378
1983 280
1984 256
1985 222
1986 288
1987 191
1988 216
1989 270
1990 264
1991 275
1992 291
1993 298
1994 293
1995 282
1996 302
1997 313
1998 286
1999 340
2000 437
2001 383
2002 390
2003 389
2004 463
2005 524
2006 561
2007 577
2008 621
2009 660
2010 644
2011 688
2012 712
2013 740
2014 806
2015 776
2016 822
2017 717
2018 773
2019 754
2020 1039
2021 1090
2022 1104
2023 987
2024 932
2025 514

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30,528 results

Results by year

Filters applied: . Clear all
Page 1
Tuberculosis vaccine: A journey from BCG to present.
Fatima S, Kumari A, Das G, Dwivedi VP. Fatima S, et al. Life Sci. 2020 Jul 1;252:117594. doi: 10.1016/j.lfs.2020.117594. Epub 2020 Apr 16. Life Sci. 2020. PMID: 32305522 Review.
As a result of intense research in understanding TB vaccinology, there are many new vaccine candidates in clinical development and many more in pre-clinical trials which aim either to replace or boost BCG vaccine. This review discusses the history of BCG vaccine …
As a result of intense research in understanding TB vaccinology, there are many new vaccine candidates in clinical development and ma …
Tuberculosis Vaccine Development: Progress in Clinical Evaluation.
Sable SB, Posey JE, Scriba TJ. Sable SB, et al. Clin Microbiol Rev. 2019 Oct 30;33(1):e00100-19. doi: 10.1128/CMR.00100-19. Print 2019 Dec 18. Clin Microbiol Rev. 2019. PMID: 31666281 Free PMC article. Review.
Tuberculosis (TB) is the leading killer among all infectious diseases worldwide despite extensive use of the Mycobacterium bovis bacille Calmette-Guerin (BCG) vaccine. ...These breakthroughs, based on the greatly expanded knowledge of the M. tuberculosis infe …
Tuberculosis (TB) is the leading killer among all infectious diseases worldwide despite extensive use of the Mycobacterium bovis baci …
The status of tuberculosis vaccine development.
Schrager LK, Vekemens J, Drager N, Lewinsohn DM, Olesen OF. Schrager LK, et al. Lancet Infect Dis. 2020 Mar;20(3):e28-e37. doi: 10.1016/S1473-3099(19)30625-5. Epub 2020 Jan 31. Lancet Infect Dis. 2020. PMID: 32014117 Review.
The spread of strains resistant to multiple drugs adds additional urgency to the vaccine development effort yet attempts to develop new vaccines with wider applicability and better, longer-lasting efficacy than BCG-the only tuberculosis vaccine license …
The spread of strains resistant to multiple drugs adds additional urgency to the vaccine development effort yet attempts to develop n …
Implications of subclinical tuberculosis for vaccine trial design and global effect.
Churchyard GJ, Houben RMGJ, Fielding K, Fiore-Gartland AL, Esmail H, Grant AD, Rangaka MX, Behr M, Garcia-Basteiro AL, Wong EB, Hatherill M, Mave V, Dagnew AF, Schmidt AC, Hanekom WA, Cobelens F, White RG. Churchyard GJ, et al. Lancet Microbe. 2024 Oct;5(10):100895. doi: 10.1016/S2666-5247(24)00127-7. Epub 2024 Jul 1. Lancet Microbe. 2024. PMID: 38964359 Free PMC article. Review.
Evaluating the efficacy of prevention of disease tuberculosis vaccines intended for preventing both clinical and subclinical tuberculosis is a priority. Incorporation of subclinical tuberculosis as a composite endpoint in tuberculosis vaccine …
Evaluating the efficacy of prevention of disease tuberculosis vaccines intended for preventing both clinical and subclinical …
Integrating fish models in tuberculosis vaccine development.
Saralahti AK, Uusi-Mäkelä MIE, Niskanen MT, Rämet M. Saralahti AK, et al. Dis Model Mech. 2020 Aug 23;13(8):dmm045716. doi: 10.1242/dmm.045716. Dis Model Mech. 2020. PMID: 32859577 Free PMC article. Review.
Currently, there is only one vaccine against tuberculosis, the Bacillus Calmette-Guerin (BCG) vaccine. Despite widespread vaccination programmes, over 10 million new M. tuberculosis infections are diagnosed yearly, with almost half a million cases caus …
Currently, there is only one vaccine against tuberculosis, the Bacillus Calmette-Guerin (BCG) vaccine. Despite widespre …
Liposomal delivery system/adjuvant for tuberculosis vaccine.
Moradi M, Vahedi F, Abbassioun A, Ramezanpour Shahi A, Sholeh M, Taheri-Anganeh M, Dargahi Z, Ghanavati R, Khatami SH, Movahedpour A. Moradi M, et al. Immun Inflamm Dis. 2023 Jun;11(6):e867. doi: 10.1002/iid3.867. Immun Inflamm Dis. 2023. PMID: 37382263 Free PMC article. Review.
Until now, various methodologies have been proposed for the development of a protein subunit vaccine for TB. These vaccines have shown higher protection than other vaccines, particularly the Bacillus culture vaccine. ...Clinical studies can provide val …
Until now, various methodologies have been proposed for the development of a protein subunit vaccine for TB. These vaccines ha …
Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.
Nemes E, Geldenhuys H, Rozot V, Rutkowski KT, Ratangee F, Bilek N, Mabwe S, Makhethe L, Erasmus M, Toefy A, Mulenga H, Hanekom WA, Self SG, Bekker LG, Ryall R, Gurunathan S, DiazGranados CA, Andersen P, Kromann I, Evans T, Ellis RD, Landry B, Hokey DA, Hopkins R, Ginsberg AM, Scriba TJ, Hatherill M; C-040-404 Study Team. Nemes E, et al. N Engl J Med. 2018 Jul 12;379(2):138-149. doi: 10.1056/NEJMoa1714021. N Engl J Med. 2018. PMID: 29996082 Free PMC article. Clinical Trial.
BACKGROUND: Recent Mycobacterium tuberculosis infection confers a predisposition to the development of tuberculosis disease, the leading killer among global infectious diseases. H4:IC31, a candidate subunit vaccine, has shown protection against tuberculosi …
BACKGROUND: Recent Mycobacterium tuberculosis infection confers a predisposition to the development of tuberculosis disease, t …
Therapeutic Vaccines for Tuberculosis: An Overview.
Bouzeyen R, Javid B. Bouzeyen R, et al. Front Immunol. 2022 Jun 24;13:878471. doi: 10.3389/fimmu.2022.878471. eCollection 2022. Front Immunol. 2022. PMID: 35812462 Free PMC article. Review.
Tuberculosis (TB), caused by Mycobacterium tuberculosis is the world's deadliest bacterial infection, resulting in more than 1.4 million deaths annually. ...Several candidate therapeutic vaccines, using killed whole-cell or live attenuated mycobacteria, mycob …
Tuberculosis (TB), caused by Mycobacterium tuberculosis is the world's deadliest bacterial infection, resulting in more than 1 …
Insights and challenges in tuberculosis vaccine development.
McShane H. McShane H. Lancet Respir Med. 2019 Sep;7(9):810-819. doi: 10.1016/S2213-2600(19)30274-7. Epub 2019 Aug 12. Lancet Respir Med. 2019. PMID: 31416767 Review.
Tuberculosis vaccine development is difficult and slow. Substantial progress has been made in research and development of tuberculosis vaccines in the past 20 years, and two clinical trial results from 2018 provide reason for optimism. However, many ch …
Tuberculosis vaccine development is difficult and slow. Substantial progress has been made in research and development of t …
The tuberculosis vaccine challenge.
[No authors listed] [No authors listed] Bull World Health Organ. 2023 May 1;101(5):303-304. doi: 10.2471/BLT.23.020523. Bull World Health Organ. 2023. PMID: 37131944 Free PMC article.
The development of effective tuberculosis vaccines requires significant advances in knowledge and methods and a massive increase in investment. ...
The development of effective tuberculosis vaccines requires significant advances in knowledge and methods and a massive increa …
30,528 results
You have reached the last available page of results. Please see the User Guide for more information.